NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • Hear from our Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page
Neuro-Bio new publication – Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer’s Disease

Neuro-Bio new publication – Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer’s Disease

Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings...
Neuro-Bio is joining the newly formed Employer Advisory Board at Nottingham Trent University and the Biosciences Department

Neuro-Bio is joining the newly formed Employer Advisory Board at Nottingham Trent University and the Biosciences Department

Sara Garcia Ratés, CSO at Neuro-Bio, will be representing Neuro-Bio together with members of other industries such Big Pharma in this collaboration of academia and industry. The board will provide advice and support to develop the University curriculum, initiate more...
Baroness Greenfield is speaking at the Brain Innovation Day Conference in Brussels – November 2024!

Baroness Greenfield is speaking at the Brain Innovation Day Conference in Brussels – November 2024!

The 4th edition of the Brain Innovation Days, organised by the European Brain Council, will take place on 13-14 November 2024 in Brussels, Belgium. The aim of the event is to bring the wider brain ecosystem together to foster dialogue,...
Baroness Greenfield speaks at the Longevity Nation 2024 Conference – October 2024!

Baroness Greenfield speaks at the Longevity Nation 2024 Conference – October 2024!

Baroness Greenfield spoke online at the Longevity Nation Conference on 28th October 2024, where she spoke about a novel mechanism underlying ageing. Click here to read more about the conference
Baroness Greenfield speaks at the House of Lords debates on the contribution of science and technology to the UK economy

Baroness Greenfield speaks at the House of Lords debates on the contribution of science and technology to the UK economy

On October 31, 2024, Baroness Susan Greenfield delivered a thought-provoking speech in the House of Lords on the critical impact of science and technology on the UK economy. She emphasized the need for enhanced investment in biotech, especially for tackling...
Purity Products podcast with Baroness Susan Greenfield

Purity Products podcast with Baroness Susan Greenfield

Baroness Greenfield discusses Neuro-degeneration, symptoms of degenerative diseases and an overview of Neuro-Bio and what we are currently working on and towards. Click here to hear the full podcast
« Older Entries
Next Entries »

LATEST NEWS

  • Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology
  • New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
  • Neuro-Bio’s first paper of 2026 has been published!
  • Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
  • CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures

TOPICS

  • Latest News
  • Media
  • Publications

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025